Antimicrobial Resistance (AMR) Genotyping Panels Global Market Report 2025
상품코드:1889301
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
항생제 내성(AMR) 지노타이핑 패널 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 12억 6,000만 달러로 평가되었고, 2025년에는 14억 5,000만 달러에 달할 것으로 추정되며, CAGR 14.6%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 진단 인프라 확충, 감염증 증가로 인한 부담 증가, 항생제 오용 및 과다 사용 증가, 헬스케어 비용 증가, 항생제 내성(AMR)에 대한 인식 증가로 인한 것으로 예측됩니다.
항생제 내성(AMR) 지노타이핑 패널 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 24억 6,000만 달러에 달할 것으로 예측되며, CAGR 14.2%로 성장할 전망입니다. 예측 기간의 성장은 지노타이핑 패널에 대한 수요 증가, 공중 보건 기관 간의 협력 강화, 확립된 헬스케어 시스템 존재, AMR에 대한 인식 증가, 진단 인프라의 지속적인 확장과 관련이 있습니다. 예측 기간 동안 예상되는 주요 동향으로는 지노타이핑 기술의 발전, 고급 분자진단 통합, 차세대 시퀀싱(NGS) 도입, 고처리량 PCR 기반 플랫폼 활용, 클라우드 기반 분석 기술의 발전 등이 있습니다.
항생제 내성 감염증 증가 경향은 향후 수년간 항생제 내성(AMR) 지노타이핑 패널 시장의 성장을 이끌 것으로 예측됩니다. 항생제 내성 감염은 박테리아, 바이러스, 곰팡이, 기생충 등의 미생물이 표준 항균제 치료를 견디는 메커니즘을 진화시킴으로써 발생하여 감염증의 치료를 더욱 어렵게 만듭니다. 항생제의 과잉 사용과 오용은 내성 병원체의 발생을 가속시키고 내성 유전자를 신속하게 검출함과 동시에, 표적을 좁힌 항균 요법을 이끄는 AMR 지노타이핑 패널의 필요성을 높이고 있습니다. 예를 들어, 미국 질병 예방 관리 센터(CDC)에 따르면, 미국에서는 연간 280만 건 이상의 항생제 내성 감염이 발생하고 있습니다. 따라서, 항생제 내성 감염 증가 경향은 AMR 지노타이핑 패널 시장의 성장에 기여합니다.
항생제 내성(AMR) 지노타이핑 패널 시장의 주요 기업은 멀티플렉스 PCR 기반의 연구용 분석 등 혁신적인 제품 개발에 주력하고 있습니다. 이를 통해 단일 검사로 여러 병원체와 항생제 내성 유전자를 동시에 검출할 수 있어, 연구 효율의 향상과 새로운 내성 패턴의 신속한 특정이 실현됩니다. 다중 PCR 기반 조사 분석은 단일 반응으로 여러 유전 표적을 증폭 및 검출하는 분자 검사로 병원체 및 내성 유전자를 동시에 확인합니다. 예를 들어 2025년 9월 미국에 거점을 두고 있는 분자진단 및 조사용 분석 기업인 Molecular Designs사는 'Urogenital Microbiota with ABX 53 Simplicity Panel'을 발매했습니다. 이 다중 PCR 기반 조사 분석은 단일 검사로 요로 병원체와 항생제 내성 유전자를 검출합니다. 대상은 28종의 비뇨 생식기 및 요로 미생물(세균 20종, 진균 7종, 원충 1종)과 25종의 항생제 내성 유전자 마커입니다. 같은 날 결과 제공이 가능하며, 96 웰 플레이트 및 384 웰 플레이트의 양 포맷으로 이용하실 수 있습니다. 96 웰판에는 폐기물 감축을 위해 분할 패널이 채용되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 항생제 내성(AMR) 지노타이핑 패널 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 항생제 내성(AMR) 지노타이핑 패널 시장 : 성장률 분석
세계의 항생제 내성(AMR) 지노타이핑 패널 시장 실적 : 규모 및 성장(2019-2024년)
세계의 항생제 내성(AMR) 지노타이핑 패널 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 항생제 내성(AMR) 지노타이핑 패널 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 항생제 내성(AMR) 지노타이핑 패널 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
커스텀 패널
사전 설계된 패널
세계의 항생제 내성(AMR) 지노타이핑 패널 시장 : 기술별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
중합효소 연쇄반응(PCR) 베이스
마이크로어레이 베이스
차세대 시퀀싱(NSG) 베이스
기타 기술
세계의 항생제 내성(AMR) 지노타이핑 패널 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
임상 진단
연구
의약품 개발
기타 용도
세계의 항생제 내성(AMR) 지노타이핑 패널 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원 및 진료소
연구기관
제약 및 바이오테크놀러지 기업
기타 최종 사용자
세계의 항생제 내성(AMR) 지노타이핑 패널 시장 : 커스텀 패널 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원체 특이적 패널
내성 유전자 특화 패널
다중 검출 패널
표적 변이 패널
조사용 용도 패널
세계의 항생제 내성(AMR) 지노타이핑 패널 시장 : 사전 설계된 패널 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
표준화 진단 패널
광역 내성 패널
질병 특이적 패널
시판 검증 완료 패널
즉용형 스크리닝 패널
제7장 지역별 및 국가별 분석
세계의 항생제 내성(AMR) 지노타이핑 패널 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 항생제 내성(AMR) 지노타이핑 패널 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
항생제 내성(AMR) 지노타이핑 패널 시장 : 경쟁 구도
항생제 내성(AMR) 지노타이핑 패널 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
F Hoffmann La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Illumina Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
bioMerieux SA. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bruker Corporation
QIAGEN NV.
Cepheid Inc.
Integrated DNA Technologies Inc.
Seegene Inc.
Oxford Nanopore Technologies plc.
Streck Inc.
MedGenome Inc.
Vela Diagnostics Pte. Ltd.
Agena Bioscience Inc.
CD Genomics Inc.
Curetis GmbH
T2 Biosystems Inc.
3B BlackBio Biotech India Ltd.
Genefirst Ltd.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
항생제 내성(AMR) 지노타이핑 패널 시장(2029년) : 새로운 기회를 제공하는 국가
항생제 내성(AMR) 지노타이핑 패널 시장(2029년) : 새로운 기회를 제공하는 부문
항생제 내성(AMR) 지노타이핑 패널 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Antimicrobial resistance (AMR) genotyping panels are advanced molecular diagnostic tools used to detect, identify, and analyze genes linked to antimicrobial resistance in bacteria and other pathogens. They allow the simultaneous screening of multiple resistance markers, enabling faster and more accurate identification of resistant strains.
The primary components of AMR genotyping panels include custom panels and pre-designed panels. AMR genotyping custom panels are specialized molecular testing panels created to detect specific genetic markers responsible for antimicrobial resistance in bacteria, viruses, or other pathogens. The technologies used include polymerase chain reaction (PCR)-based methods, microarray-based methods, next-generation sequencing (NGS)-based methods, and others, which support applications in clinical diagnostics, research, drug development, and other specialized fields. These panels are utilized by hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and other healthcare and scientific organizations.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The antimicrobial resistance (AMR) genotyping panels market research report is one of a series of new reports from The Business Research Company that provides antimicrobial resistance (AMR) genotyping panels market statistics, including antimicrobial resistance (AMR) genotyping panels industry global market size, regional shares, competitors with an antimicrobial resistance (AMR) genotyping panels market share, detailed antimicrobial resistance (AMR) genotyping panels market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial resistance (AMR) genotyping panels industry. This antimicrobial resistance (AMR) genotyping panels market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The antimicrobial resistance (AMR) genotyping panels market size has grown rapidly in recent years. It will grow from $1.26 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. Growth during the historic period can be attributed to the expansion of diagnostic infrastructure, the rising burden of infectious diseases, increasing misuse and overuse of antibiotics, higher healthcare expenditure, and greater awareness of antimicrobial resistance (AMR).
The antimicrobial resistance (AMR) genotyping panels market size is expected to see rapid growth in the next few years. It will grow to $2.46 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. Growth in the forecast period can be linked to the rising demand for genotyping panels, collaborative efforts among public health agencies, the presence of established healthcare systems, growing awareness of AMR, and continued expansion of diagnostic infrastructure. Key trends expected during the forecast period include advancements in genotyping technologies, the integration of advanced molecular diagnostics, the adoption of next-generation sequencing (NGS), the use of high-throughput PCR-based platforms, and technological progress in cloud-based analytics.
The rising prevalence of antimicrobial-resistant infections is expected to drive the growth of the antimicrobial resistance (AMR) genotyping panels market in the coming years. Antimicrobial-resistant infections are caused by microorganisms-including bacteria, viruses, fungi, or parasites-that have evolved mechanisms to withstand standard antimicrobial treatments, making infections more difficult to treat. The overuse and misuse of antibiotics have accelerated the development of resistant pathogens, increasing the need for AMR genotyping panels that can rapidly detect resistance genes and guide targeted antimicrobial therapy. For example, according to the Centers for Disease Control and Prevention (CDC), over 2.8 million antimicrobial-resistant infections occur annually in the United States. Therefore, the rising prevalence of antimicrobial-resistant infections is contributing to the growth of the AMR genotyping panels market.
Key players in the antimicrobial resistance (AMR) genotyping panels market are focusing on innovative product development, such as multiplex PCR-based research assays, to enable simultaneous detection of multiple pathogens and antibiotic resistance genes in a single test, thereby improving research efficiency and accelerating the identification of emerging resistance patterns. Multiplex PCR-based research assays are molecular tests that amplify and detect multiple genetic targets in a single reaction to identify pathogens and resistance genes simultaneously. For instance, in September 2025, Molecular Designs, a U.S.-based molecular diagnostics and research-assay company, launched the Urogenital Microbiota with ABX 53 Simplicity Panel. This multiplex PCR-based research assay detects urinary pathogens and antibiotic resistance genes in a single test, covering 28 urogenital and urinary microbial targets (20 bacterial, 7 fungal, and 1 protozoan) along with 25 antibiotic-resistance gene markers. It offers same-day turnaround and is available in both 96-well and 384-well plate formats, with breakaway panels included in the 96-well version to reduce waste.
In June 2025, bioMerieux, a France-based provider of in vitro diagnostics systems, reagents, software, and services for infectious diseases and industrial microbiology, acquired the assets of Day Zero Diagnostics for $25 million. Through this acquisition, bioMerieux aimed to strengthen its next-generation sequencing (NGS) and rapid antimicrobial-resistance diagnostics capabilities to better address infectious disease and antimicrobial resistance (AMR) challenges. Day Zero Diagnostics is a U.S.-based company specializing in rapid whole-blood sample preparation, genome sequencing, and machine-learning analytics for pathogen identification and antibiotic-resistance profiling.
Major companies operating in the antimicrobial resistance (amr) genotyping panels market are Thermo Fisher Scientific Inc., F Hoffmann La Roche Ltd., Abbott Laboratories, Illumina Inc., bioMerieux SA., Bruker Corporation, QIAGEN NV., Cepheid Inc., Integrated DNA Technologies Inc., Seegene Inc., Oxford Nanopore Technologies plc., Streck Inc., MedGenome Inc., Vela Diagnostics Pte. Ltd., Agena Bioscience Inc., CD Genomics Inc., Curetis GmbH, T2 Biosystems Inc., 3B BlackBio Biotech India Ltd., Genefirst Ltd., OpGen Inc.
North America was the largest region in the antimicrobial resistance (AMR) genotyping panels market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antimicrobial resistance (AMR) genotyping panels report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the antimicrobial resistance (AMR) genotyping panels market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The antimicrobial resistance (AMR) genotyping panels market consists of sales of qPCR antimicrobial resistance detection kits, multiplex genotyping assays, next-generation sequencing reagent kits, antimicrobial resistance reference standards, and microarray slide kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Antimicrobial Resistance (AMR) Genotyping Panels Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on antimicrobial resistance (amr) genotyping panels market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for antimicrobial resistance (amr) genotyping panels ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antimicrobial resistance (amr) genotyping panels market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Custom Panels; Pre-Designed Panels
2) By Technology: Polymerase Chain Reaction (PCR)-Based; Microarray-Based; Next-Generation Sequencing (NSG)-Based; Other Technologies
3) By Application: Clinical Diagnostics; Research; Drug Development; Other Applications
4) By End-User: Hospitals And Clinics; Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-users
Subsegments:
1) By Custom Panels: Pathogen-Specific Panels; Resistance Gene-Focused Panels; Multiplex Detection Panels; Targeted Mutation Panels; Research Application Panels
3. Antimicrobial Resistance (AMR) Genotyping Panels Market Trends And Strategies
4. Antimicrobial Resistance (AMR) Genotyping Panels Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Antimicrobial Resistance (AMR) Genotyping Panels Growth Analysis And Strategic Analysis Framework
5.1. Global Antimicrobial Resistance (AMR) Genotyping Panels PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Antimicrobial Resistance (AMR) Genotyping Panels Market
9.1. China Antimicrobial Resistance (AMR) Genotyping Panels Market Overview
9.2. China Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Antimicrobial Resistance (AMR) Genotyping Panels Market
10.1. India Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Antimicrobial Resistance (AMR) Genotyping Panels Market
11.1. Japan Antimicrobial Resistance (AMR) Genotyping Panels Market Overview
11.2. Japan Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Antimicrobial Resistance (AMR) Genotyping Panels Market
12.1. Australia Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Antimicrobial Resistance (AMR) Genotyping Panels Market
13.1. Indonesia Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Antimicrobial Resistance (AMR) Genotyping Panels Market
14.1. South Korea Antimicrobial Resistance (AMR) Genotyping Panels Market Overview
14.2. South Korea Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Antimicrobial Resistance (AMR) Genotyping Panels Market
15.1. Western Europe Antimicrobial Resistance (AMR) Genotyping Panels Market Overview
15.2. Western Europe Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Antimicrobial Resistance (AMR) Genotyping Panels Market
16.1. UK Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Antimicrobial Resistance (AMR) Genotyping Panels Market
21.1. Eastern Europe Antimicrobial Resistance (AMR) Genotyping Panels Market Overview
21.2. Eastern Europe Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Antimicrobial Resistance (AMR) Genotyping Panels Market
22.1. Russia Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Antimicrobial Resistance (AMR) Genotyping Panels Market
23.1. North America Antimicrobial Resistance (AMR) Genotyping Panels Market Overview
23.2. North America Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Antimicrobial Resistance (AMR) Genotyping Panels Market
24.1. USA Antimicrobial Resistance (AMR) Genotyping Panels Market Overview
24.2. USA Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Antimicrobial Resistance (AMR) Genotyping Panels Market
26.1. South America Antimicrobial Resistance (AMR) Genotyping Panels Market Overview
26.2. South America Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Antimicrobial Resistance (AMR) Genotyping Panels Market
27.1. Brazil Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Antimicrobial Resistance (AMR) Genotyping Panels Market
28.1. Middle East Antimicrobial Resistance (AMR) Genotyping Panels Market Overview
28.2. Middle East Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Antimicrobial Resistance (AMR) Genotyping Panels Market
29.1. Africa Antimicrobial Resistance (AMR) Genotyping Panels Market Overview
29.2. Africa Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Antimicrobial Resistance (AMR) Genotyping Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Antimicrobial Resistance (AMR) Genotyping Panels Market Competitive Landscape And Company Profiles
